Table 2: Clinical features of T2DM patients and controls.

T2DM ()Controls () value (<0.05)

Age (yrs)55.55 ± 14.3650.80 ± 12.480.068
Male (, %)53.33%46.67%0.572
BMI (kg/m2)26.55 ± 6.0125.21 ± 3.340.171
SBP (mmHg)132.17 ± 18.24127.27 ± 17.640.151
DBP (mmHg)79.28 ± 13.6671.98 ± 10.21
Waist circumference (cm)93.80 ± 13.0485.08 ± 10.18<0.00
(%)8.89 ± 2.285.34 ± 0.36<0.00
FPG (mmol/L)8.42 ± 2.915.50 ± 0.52<0.00
FC-P (ng/mL)1.55 ± 0.891.23 ± 0.52
FINS (uIU/mL)14.02 ± 10.376.07 ± 2.68<0.00
HOMA-IR4.87 ± 3.271.49 ± 0.68<0.00
CARTs total score3.23 ± 1.672.04 ± 1.58<0.00
Mean hands ESC (μS)73.75 ± 15.2578.36 ± 9.74
Mean feet ESC (μS)68.13 ± 17.9673.81 ± 9.34

Data were mean ± SD for continuous variables and (%) for categorical variables. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; FC-P, fasting C-peptide; FINS, fasting insulin; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; T2DM, type 2 diabetes mellitus; CARTs, cardiovascular reflex tests; ESC, electrochemical skin conductance; values were for one-way ANOVA or Chi-square tests across the 2 groups. . .